ArticleNeurochemical research2025
Decoupling of Neurochemical and White Matter Microstructural Integrity in Posterior Cingulate Cortex Predicts Early Alzheimer's Disease Progression.
Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by early metabolic and structural brain changes. These alterations are often detectable during mild cognitive impairment due to AD (AD-MCI), a prodromal stage of the disease. The posterior cingulate cortex (PCC), a critical brain region involved in memory and self-referential processing, is particularly vulnerable to these changes. We recruited 21 healthy controls (HC) and 20 AD-MCI patients to participate in this study. Point-Resolved Echo Spin Spectroscopy (PRESS) combined with MEGA-PRESS was employed to accurately measure levels of Gamma-Aminobutyric Acid (GABA) and Glx (Combination of Glutamate and Glutamine) in the PCC. Additionally, diffusion tensor imaging (DTI) was utilized to assess white matter (WM) microstructure integrity. Key metabolites, including N-acetylaspartate (NAA), choline (Cho), and myo-inositol (mI), were quantified to provide insights into neuronal health and metabolic status, while WM integrity was evaluated using fractional anisotropy (FA) and mean diffusivity (MD) metrics. In the PCC, AD-MCI patients exhibited a significant reduction in tNAA/tCr (1.22 ± 0.09 vs. HC 1.32 ± 0.07, p < 0.001) and NAA/mI (1.22 ± 0.12 vs. HC 1.44 ± 0.12, p < 0.001), along with an increase in mI/Cr (1.84 ± 0.28 vs. HC 1.60 ± 0.29, p = 0.012) and decreased GABA+/water (2.23 ± 0.78 vs. HC 2.98 ± 0.73, p = 0.003). Diffusion metrics revealed higher mean diffusivity in PCC-connected gray matter (GM_MD: 10.40 ± 0.79 vs. 9.53 ± 0.80 × 10⁻⁴ mm²/s, p < 0.01) and white matter (WM_MD: 0.09 ± 0.01 vs. 0.08 ± 0.01 × 10⁻² mm²/s, p < 0.01). Notably, in AD-MCI, NAA/mI was negatively correlated with WM_MD (r = - 0.462, p = 0.047), and tNAA/tCr was positively correlated with WM_FA (r = 0.580, p = 0.009). PCC neurochemical-microstructural decoupling (NAA/mI-MD dissociation with preserved tNAA/tCr-FA coupling) marks early AD progression. This dissociation pattern, reflecting concurrent neuronal dysfunction and compensatory glial responses, proposes a novel multimodal biomarker for tracking axonal degeneration prior to overt cognitive decline.
Indexed as
Identifiers
40343631What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.